Priothera

0 followers


Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Industries

+1

Headquarters

Employees

Links

Org chart

Florent Gros
CEO & Founder

Florent Gros

Collapse
Elisabeth Kueenburg
Chief Medical Officer
Stephan Oehen
Chief Operating Officer & Founder
Philippe Lievre
Chief Business Officer & Founder
Brice Suire
Chief Financial Officer & Founder
Karen Von Graevenitz
Head of Regulatory Affairs
Simone Dertschnig
Head of Research
Frédéric David
Head Technical Development